
Advanced Heart Failure and Transplant Cardiologist @MedstarWHC; APD @GTCardFellows; Associate Professor of Medicine @GUMedicine; Alum @UVMLarnerMed @Cornell
Washington, DC
Joined April 2018
- Tweets518
- Following394
- Followers714
- Likes1.5K
Phillip Lam, MD retweeted
Grateful for the opportunity to serve as visiting professor and deliver Grand Rounds at MedStar Health / Georgetown, discussing overcoming treatment inertia for patients with heart failure and cardiometabolic disease.
The central theme was simple but urgent: we have powerful therapies, better diagnostics, and growing digital capabilities, but patients only benefit when we organize care delivery around action. Overcoming inertia requires more than awareness. It requires teams, tools, and technology designed to create momentum at every clinical touchpoint.
I was proud to highlight our work through the IMPLEMENT-HF initiative and CMCA, both supported by the American Heart Association, as well as related efforts to advance practical solutions for guideline-directed care. These include leadership in remote PA pressure monitoring, digital health interventions such as the VITAL-HF study, development of the KCMO score to support GDMT uptitration, and emerging device technologies such as Acorai, including validation work in CAPTURE-HF.
Across these efforts, the goal is the same: help clinicians identify risk earlier, organize relevant data more effectively, and move from recognition to action for patients living with heart failure and cardiovascular-kidney-metabolic disease.
But the best part of the visit was getting to know colleagues at MedStar and Georgetown. It was energizing to find such clear common ground around the need to build systems that help us give patients our best with every opportunity.
Thank you to the MedStar Health / Georgetown teams for the warm welcome, thoughtful discussion, and shared commitment to combating heart failure and CKM disease.
Initiation of NB therapy during index HM3 LVAD implant associated with improved survival, a finding that needs to be prospectively studied @FlaviaTejadaF @fsheikh22 @RichaGuptaMD @MedStarHealth @GTCardFellows @IMMWHC onlinelibrary.wiley.com/doi/…
HF phenotyping using AI approaches demonstrating comparable clinical outcomes to traditional ICD coding, suggesting potential utility of AI to improve care, operations, and research @aamdmph @gcfmd @JCardFail @GTCardFellows @fsheikh22 @MedStarHealth @DCVAMC
Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry - Journal of Cardiac Failure onlinejcf.com/article/S1071-…
@aamdmph @boback @ATSandhu @JCardFail
Phillip Lam, MD retweeted
Only a few years ago, financial literacy in medicine was an almost-taboo topic most of us preferred to ignore. Today, it is front & center in the #PhysicianWellness conversation where it belongs.
🙏 to the @ACCinTouch PGDME Council for organizing this important #ACC26 session!
Looking forward to attending the #ACC26 PDGME recommended sessions including the symposium on 3/27! @ACCinTouch @docbfreed @gabyweissman @ckaiseroll @MarkHofmeyer @MedStarHealth @GTCardFellows
Phillip Lam, MD retweeted
Love that @ACCinTouch is putting #FinancialWellness front and center!
Attending #ACC26 next weekend? Join me and other experts at the Heart2Heart Stage on 3/29 at 9AM for a discussion on critical financial literacy topics we all need to understand. @ACCMaryland @UM_Cardiology
Early career professionals, come check out our financial literacy 101 session at #ACC26! Important topics to be covered! #accpdgme @Stanley_Liu_MD @DrToniyaSingh @ACCinTouch @SelmaFMohammed @GTCardFellows @RichaGuptaMD @fsheikh22 @WaqasHaiderMD @acc
Early career professionals, come check out our financial literacy 101 session at #ACC26! Important topics to be covered! #accpdgme @Stanley_Liu_MD @DrToniyaSingh @ACCinTouch @SelmaFMohammed @GTCardFellows @RichaGuptaMD @fsheikh22 @WaqasHaiderMD @acc
Findings from our study demonstrate that in patients with HFrEF, target dose ACEIs were associated with lower risk of kidney failure and death academic.oup.com/eurjhf/adva… @gcfmd @DCVAMC @MedStarHealth
Phillip Lam, MD retweeted
This is misinformation.
The Cochrane review on influenza vaccines in children found inactivated vaccines reduce the risk of influenza by 64% (high-certainty evidence) and live attenuated vaccines by 78% (moderate-certainty evidence).
On hospitalizations and deaths, Cochrane stated they “found no data on hospitalisation” — meaning no RCTs measured this outcome. That’s completely different from finding “no evidence of benefit.” Absence of evidence does not equal evidence of absence.
Cochrane’s strict RCT-only methodology isn’t designed to capture rare outcomes like deaths. Observational studies consistently show flu vaccines reduce pediatric hospitalizations and mortality.
RFK Jr. is exploiting a methodological nuance to mislead the public about a vaccine that protects children.
RFK Jr. suggests fewer people getting the flu vaccine may be a good thing.
Reporter: “So fewer people will get the flu vaccine?”
RFK Jr: “Maybe that’s a better thing.”
“The Cochrane Collaboration, one of the ultimate arbiters of vaccine safety and clinical data, has done an extensive meta-review of the flu vaccine.”
“They found that there is no evidence it prevents serious disease, hospitalizations, or death in children.”
Use of oral Mg and outcomes in U.S. Veterans with HF @DCVAMC @gcfmd @MedStarWHC @fsheikh22 @RichaGuptaMD @GTCardFellows
Replying to @HanCardiomd
👥 54 696 Veterans with HF (2001–2023)
📌Hypomagnesemia (<1.7 mg/dL):
Oral magnesium (median 420 mg/day) reduced 1-yr HF 🏥/death☠️(HR 0.91).
Strongest benefit when Mg <1.3 mg/dL (HR 0.81).
📌Normomagnesemia (1.7–2.3 mg/dL):
Supplementation associated with worse outcomes (HR 1.11).
🔍 Spline analysis: Benefit seen when Mg <1.5, harm when >1.8 mg/dL.
Implication
academic.oup.com/eurheartj/a… @ehj_ed @ESC_Journals
Phillip Lam, MD retweeted
Excited to announce our incoming group of outstanding fellows for the year 2026. Welcome to @GTCardFellows and congratulations! @gabyweissman @PhilLamMD @ckaiseroll @fsheikh22 @RichaGuptaMD @sumbaljanjuamd @AnamWaheed05 @DrGermanMD @MarkHofmeyer @CyrusHadadiMD @HashimHayder
Looking forward to working with this next group of excellent fellows!
This quoted post is unavailable.
7
1,285
Use of digital platform demonstrating improved optimization of HF GDMT in HFrEF. Thanks to those who were involved with enrollment for this important clinical study @MedStarWHC! @fsheikh22 @miguelpinillav @RichaGuptaMD @MedStarHealth @gcfmd @biofourmis @MarkHofmeyer
RCT demonstrating improved HF optimal therapy score and use of quadruple GDMT with a digital system
Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial | Circulation: HF ahajournals.org/doi/10.1161/…
@texhern @CircHF @biofourmis
Congrats @FlaviaTejadaF on your excellent oral abstract presentation on early RVF in HM3 recipients at #AHA2025! Way to represent! @fsheikh22 @RichaGuptaMD @miguelpinillav @MarkHofmeyer @MedStarWHC @IMMWHC @GTCardFellows @ZekeMolinaMD
Congrats to former all-star @GTCardFellows chief @merhussien on the publication of this challenging case! @gabyweissman @MedStarWHC @ckaiseroll
This was a challenging and unfortunate case of massive LV thickening right after HM3 implantation at our center, without evidence of edema/sig inflammation on serial biopsies! @AlexPapolos
@fsheikh22 @PhilLamMD @GTCardFellows @MedStarWHC
5
995
Our analysis on the clinical impact of RVAD timing and outcomes in HM3 recipients with early severe RVF @MLorenteRos @fsheikh22 @GTCardFellows @RichaGuptaMD @miguelpinillav @BKenigsberg @ZekeMolinaMD @MedStarHealth @MedStarWHC sciencedirect.com/science/ar…
Great opportunity to work with a great team! @fsheikh22
1
385
Phillip Lam, MD retweeted
It was truly an honor to participate in #ESCCongress2025 and learn from 20 NEJM and >30 EHJ publications shaping the future of cardiology, along with a special message from @CasaReal.
Thank you to @PhilLamMD and @fsheikh22 for making this possible!
@escardio @GTCardFellows
Congrats to all-star resident @FlaviaTejadaF on an excellent abstract on early use of NB in HM3 LVAD recipients and outcomes! Way to represent our program! @fsheikh22 @MedStarHealth @RichaGuptaMD @miguelpinillav @MedStarWHC @GTCardFellows
Congrats to our all-star chief fellow @MLorenteRos on her oral presentation at #ESCCongress2025 on predictors of successful RVAD wean in patients undergoing HM3 LVAD with RVF! @GTCardFellows @gabyweissman @ckaiseroll @fsheikh22 @miguelpinillav @RichaGuptaMD



























